Nyxoah SA

NYXH Nasdaq SEC CIK 1857190
Follow Nyxoah Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 EUR · IFRS
Revenue, last year €10M +121.6% vs prior year
Net income −€90.1M −52.1% vs prior year
EPS, diluted −€2.36 −30.7% vs prior year
Operating cash flow −€69M −40.1% vs prior year
Revenue by fiscal year
€69K
€852K
€3.1M
€4.3M
€4.5M
€10M
FY20 FY21 FY22 FY23 FY24 FY25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−€100M−€50M€0€50MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25€10M−€90.1M
FY24€4.5M−€59.2M
FY23€4.3M−€43.2M
FY22€3.1M−€31.2M
FY21€852K−€27.6M
FY20€69K−€12.2M
FY19--
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%5000%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2563.1%−833.2%−899.1%
FY2465.7%−1300.8%−1310.2%
FY2361.9%−1037.3%−993.8%
FY2262.7%−1053.8%−1012.5%
FY2164.4%−3080%−3241.7%
FY2056.5%−16266.7%−17746.4%
FY19---
FY18---
Free cash flowOperating cash flow minus capital expenditure
−€80M−€60M−€40M−€20M€0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−€69.8M
FY24−€50.4M
FY23−€47.3M
FY22−€29.6M
FY21−€26.8M
FY20−€7.4M
FY19−€6M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Nyxoah
  • Healthcare median
−20000%−15000%−10000%−5000%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearNyxoahHealthcare median
FY25−899.1%−30.6%
FY24−1310.2%−47%
FY23−993.8%−58%
FY22−1012.5%−80.4%
FY21−3241.7%−71.8%
FY20−17746.4%−62.2%
FY19-−46.2%
FY18-−49.6%